RT Journal Article
SR Electronic
T1 Trans-Tenon’s retrobulbar triamcinolone infusion for the treatment of uveitis
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 968
OP 971
DO 10.1136/bjo.87.8.968
VO 87
IS 8
A1 A A Okada
A1 T Wakabayashi
A1 Y Morimura
A1 S Kawahara
A1 E Kojima
A1 Y Asano
A1 T Hida
YR 2003
UL http://bjo.bmj.com/content/87/8/968.abstract
AB Aim: To assess efficacy and complications of trans-Tenon’s retrobulbar infusion of triamcinolone acetonide for posterior uveitic inflammation. Methods: Non-randomised, uncontrolled, retrospective study of 51 eyes of 37 patients who underwent triamcinolone infusion for vitritis, cystoid macular oedema (CMO), or posterior retinal vasculitis using a long blunt cannula via an incision made through conjunctiva and Tenon’s capsule. Results: Overall clinical efficacy was 86%; 96% for vitritis, 82% for CMO, and 33% for posterior retinal vasculitis. Mean visual acuity improved within 1 month after triamcinolone infusion (p <0.05). Cataract progression and intraocular pressure elevation were observed in 31% and 27% of eyes, respectively. Conclusion: Trans-Tenon’s retrobulbar triamcinolone infusion may be a safe and effective treatment for posterior uveitic inflammation.